Cantor Fitzgerald analyst Sarah James reiterates HCA Healthcare (NYSE:HCA) with a Overweight and maintains $392 price target.
Cantor Fitzgerald Reiterates Overweight on HCA Healthcare, Maintains $392 Price Target
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.